Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Zhi Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6793-9560; OpenAlex author ID A5100382297. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 2 papers

Papers 2

  1. DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1-mediated antioxidant effects. Co-author DOI 10.1111/jcmm.16196↗
  2. A Ductal-Cell-Related Risk Model Integrating Single-Cell and Bulk Sequencing Data Predicts the Prognosis of Patients With Pancreatic Adenocarcinoma. Last author DOI 10.3389/fgene.2021.763636↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xitao Wang · 1 shared paper, 2021 · strength 0.14
  2. Wenhui Lou · 1 shared paper, 2021 · strength 0.12
  3. Jian-ang Li · 1 shared paper, 2021 · strength 0.12
  4. Xu Han · 1 shared paper, 2021 · strength 0.12
  5. Yuan Fang · 1 shared paper, 2021 · strength 0.12
  6. Yefei Rong · 1 shared paper, 2021 · strength 0.12
  7. Tiantao Kuang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.